On November 10, 2009
Scandal Provides Another Reason Omeros Might Not Be the Biotech IPO Bellwether
Omeros Corp.’s recent IPO flop may be due to factors other than a lack of investor appetite for the biotech sector: the company is embroiled in a wrongful termination lawsuit with claims of defrauding the NIH and lying about taxes.
0 Comments